Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

cbdMD (YCBD) Change in Acquisitions & Divestments (2020)

cbdMD's Change in Acquisitions & Divestments history spans 1 years, with the latest figure at $540000.0 for Q4 2020.

On a quarterly basis, Change in Acquisitions & Divestments changed N/A to $540000.0 in Q4 2020 year-over-year; TTM through Sep 2022 was $540000.0, a N/A change, with the full-year FY2023 number at $1.0 million, changed N/A from a year prior.
Change in Acquisitions & Divestments hit $540000.0 in Q4 2020 for cbdMD.
Over the last five years, Change in Acquisitions & Divestments for YCBD hit a ceiling of $540000.0 in Q4 2020 and a floor of $540000.0 in Q4 2020.